Literature DB >> 12558790

Surgery in severe factor XIII deficiency: report of a case of epilepsy neurosurgery and review.

G Pernod1, C Barro, B Arnutti, F Blanc-Jouvan, S Garrel, P Kahn, L Minotti, A Koudsie, A L Benabid, I Wrobleski, A Joannard, B Polack.   

Abstract

Factor XIII (FXIII) deficiency is a rare autosomal recessive congenital disorder of haemostasis, associated with a high risk of intracranial haemorrhage. Intracranial haemorrhage can result in neurological sequelae including seizure disorders. In some cases, medically intractable epilepsy led to epilepsy surgery. Little has been reported on the management of FXIII deficiency during surgery, and there is only a few data on the management, safety and efficacy of epilepsy surgery in the patients with haemostatic disorder. We report here an epilepsy neurosurgery in a case of severe FXIII deficiency.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12558790     DOI: 10.1046/j.1365-2516.2003.00700.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  3 in total

1.  Induction of hemodialysis therapy in a case with factor XIII deficiency.

Authors:  Akira Hiwatashi; Jo-Ichi Usui; Chihiro Sato; Yuichi Hasegawa; Kunihiro Yamagata
Journal:  Clin Exp Nephrol       Date:  2011-06-28       Impact factor: 2.801

Review 2.  Management of coagulopathy in the setting of acute neurosurgical disease and injury.

Authors:  Marlon Mathews; Richard Newman; E Thomas Chappell
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

3.  Successful bypass surgery for esophageal carcinoma under adequate factor XIII/13 replacement therapy in a case of intractable autoimmune hemorrhaphilia due to anti-Factor XIII/13 antibodies.

Authors:  Minoru Kojima; Akitada Ichinose; Masayoshi Souri; Tsukasa Osaki; Hidetsugu Kawai; Jun Amaki; Hiroki Numata; Mitsuki Miyamoto; Daisuke Ogiya; Kosuke Tsuboi; Yoshiaki Ogawa; Soji Ozawa; Kiyoshi Ando
Journal:  Int J Hematol       Date:  2015-11-30       Impact factor: 2.490

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.